Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients
F D Loop1, B W Lytle, D M Cosgrove
1Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Ohio 44195.
Annals of Surgery
|September 1, 1990
Summary
Reoperations for myocardial revascularization show increasing patient age and vein graft atherosclerosis as primary drivers. Despite challenges, survival rates improved due to advancements like internal thoracic artery grafts.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Trends Analysis
Background:
- Reoperation for myocardial revascularization is a complex procedure with evolving patient demographics and indications.
- Understanding long-term outcomes and trends is crucial for optimizing surgical strategies.
Purpose of the Study:
- To analyze trends in clinical, angiographic, and operative variables for myocardial revascularization reoperations.
- To document long-term survival rates and identify factors influencing outcomes over a 20-year period.
Main Methods:
- Analysis of 2509 consecutive patients undergoing reoperation for myocardial revascularization from 1967 to 1987.
- Patients were stratified into four surgical year cohorts to assess temporal trends.
- Evaluation of indications for reoperation, patient characteristics, operative details, and survival data.
Main Results:
- Vein graft atherosclerosis emerged as the leading indication for reoperation, with increasing patient age and time between surgeries.
- Hospital mortality rates remained low (2.9% in 1985-1987), despite rising comorbidity and worse left ventricular function.
- Perioperative myocardial infarction rates decreased, and internal thoracic artery graft use significantly increased (27% to 67%).
Conclusions:
- Advanced age and left main coronary artery disease negatively impacted late survival.
- Improved survival in earlier cohorts was linked to fewer risk factors.
- Factors associated with better 10-year survival included younger age, less comorbidity, good left ventricular function, and internal thoracic artery grafting.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


